Skip to main content
. Author manuscript; available in PMC: 2011 Sep 23.
Published in final edited form as: For Immunopathol Dis Therap. 2010 Jul 1;1(3):205–218. doi: 10.1615/ForumImmunDisTher.v1.i3.30

FIGURE 3.

FIGURE 3

Intravenously administered JS-K signifi cantly improved survival of mice bearing xenografts of OPM-1 multiple myeloma cells. (Adapted from Kiziltepe et al., 2007.7 Copyright American Society of Hematology.)